Almoosa Health Co.
TTADAWUL:4018103.40
SAR
-7.10
(-6.43%)
Almoosa Health Co.
TADAWUL:4018
(Saudi Exchange)
Recent
price
103.40
P/E
ratio
26.91
div
yld
0.68%
ROIC.AI
Capital Structure
SAR
•
in mil. unless spec.Working Capital
SAR
•
in mil. unless spec.Growth Rates
SAR
•
in mil. unless spec.Quarterly Revenue
SAR
•
in mil. unless spec.Quarterly Earnings Per Share
SAR
•
in mil. unless spec.Quarterly Dividends Per Share
SAR
•
in mil. unless spec.- Similar Companies
- Business
- Almoosa Health Company (4018.SR), a leading integrated healthcare provider in Saudi Arabia's Eastern Province, delivers a comprehensive continuum of care encompassing primary, acute, rehabilitative, and non-acute services; operates Almoosa Specialist Hospital with 430 beds, 245 clinics, and centers of excellence in cardiology, oncology, pediatrics, orthopedics, and critical care including 17 operating rooms, 126 critical care beds, advanced nuclear medicine, radiotherapy, and the region's only licensed medical helipad; manages Almoosa Rehabilitation Hospital with 300 beds and 300 clinics specializing in sports rehabilitation, cardio rehabilitation, neurology and stroke rehabilitation, pediatric rehabilitation, pain management, mental health via the Rafah Mental Health Center, and long-term care; provides ancillary services such as pharmaceuticals through smart outpatient and automated inpatient pharmacies, home healthcare, telemedicine including virtual visits and tele-pharmacy, and laboratory and radiology services accredited by international bodies; and offers academic training programs as an accredited teaching hospital. Founded in 1996 as Almoosa General Hospital in Al-Ahsa with 30 beds and headquartered there, the company rebranded to Al Moosa Specialist Hospital in 2014, expanded capacity to 730 beds across its facilities by 2024, converted to a joint-stock company, and listed on the Saudi Exchange (Tadawul) main market in January 2025 following a successful IPO with cornerstone commitments from Tawuniya and Alfozan Holding. Recent developments include a 22.8% revenue increase to SAR 1.2 billion and 37.8% EBITDA growth to SAR 270.3 million in 2024 driven by 18.4% rises in patient volume to over 1.1 million and clinic count to 290; expansion of 45 new specialty clinics across orthopedics, ophthalmology, pediatrics, endocrinology, and OB/GYN; launch of the Peak Performance Sports Center and Rafah Mental Health Center as the Eastern Province's first comprehensive mental health facility; partnerships with Bupa Arabia, Tawuniya, and SABIC for enhanced insurance and corporate wellness; a 25-year lease agreement with Abdullah Al Othaim Investment for an 18,000 sqm medical center in Jubail Industrial City starting February 2026; ongoing construction of three primary care centers in Al-Ahsa, Al-Khobar, and Dammam under a "hub and spoke" model to open five by 2027 in support of Saudi Vision 2030; and development of two new acute-care hospitals in Al-Khobar and Al-Hofuf slated for completion by 2028 to double bed capacity.